Nightly News | December 16, 2010
FDA: Avastin not safe for breast cancer treatment
The FDA is recommending the drug Avastin be removed from the market as a treatment for breast cancer because of serious side-effects in patients, including high blood pressure, bleeding and heart failure. NBC's Brian Williams reports.
Share This:
Health
-
Accidental drowning biggest risk for kids
NBC News
May 22, 2013 -
For Oklahoma doctors and first responders, an emotional 24 hours
Nightly News
May 21, 2013 -
Parents call twins' separation surgery 'miracle'
NBCNews.com
May 21, 2013 -
First responders ‘instrumental’ in rescue efforts
TODAY
May 21, 2013 -
New guidelines have Asperger’s families worried
Nightly News
May 19, 2013 -
More young people having strokes, study says
Nightly News
May 18, 2013 -
Student: 'We're graduating a premier group of new doctors'
Nightly News
May 17, 2013 -
New IVF technology offers dramatic results
Nightly News
May 17, 2013 -
Medical research impacted by continuing sequester
Hardball
May 17, 2013 -
Can genetic testing help women prevent a breast cancer diagnosis?
Mitchell Reports
May 17, 2013 -
Flesh-eating bacteria victim gets new bionic hands
NBC News
May 17, 2013 -
Calorie-cutting condiments help trim weight
TODAY
May 17, 2013
This content comes from a Full-Text Transcript of the program.
BRIAN WILLIAMS, anchor: recommending Avastin be removed from the market as a treatment for breast cancer because its risks outweighed its benefits. Avastin was approved in '08, but since then patients, as you may know, have
had serious side effects: high blood pressure, bleeding, heart failure. The drug will remain an approved treatment for some other types of cancer, including brain and lung cancer .